Exosome Therapy vs. Stem Cell Grafts: The $20,000 Question in Executive Longevity
Stem cells or Exosome therapy? Comparing $25,000 protocols for Executive Longevity. Discover the ROI of Regenerative Medicine and how to avoid grey-market clinic traps in 2026. The era of the “annual physical” is dead for the C-suite. In 2026, the elite are no longer waiting for symptoms to appear; they are investing in cellular optimization. … Read more